[ad_1]
() raised a total of £ 785,000 through an equity placement to enable it to increase its investments in the token blockchain community. George McDonaugh, CEO of KR1, tells Proactive London how, although the cryptographic currencies are new and still lagging behind liquidity in terms of trust, they represent the undeniable way to proceed.
The investor of the blockchain and the cryptocurrency stated that the placement of 15,700,000 ordinary shares was made at a price of 5p per share by Peterhouse Capital. McDonaugh also explains where the money will be spent.
We meet Alliance Pharma PLC, IXICO PLC, Benchmark Holdings PLC, Clinigen Group PLC and Shield Therapeutics PLC at our event,
London, 24 January 2019.
Register here "
